Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 1, 2026

Smartphones Market Worth USD 739.23 Billion by 2031 with Android Segment Holding 69.21% Market Share and AI Adoption Accelerates Growth, Reports Mordor Intelligence

View original at globenewswire.com
Smartphones Market Worth USD 739.23 Billion by 2031 with Android Segment Holding 69.21% Market Share and AI Adoption Accelerates Growth, Reports Mordor Intelligence Hyderabad, India, June 01, 2026 (GLOBE NEWSWIRE) -- Mordor Intelligence has published a new report on the smartphones market, providing a comprehensive ana…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Smartphone vendors are focusing on foldable designs, on-device AI functionality, and sustainable manufacturing practices to strengthen their competitive positioning.

    60% confidence
  • The Middle East is witnessing increasing demand for advanced smartphones, driven by digital transformation initiatives and growing interest in premium mobile experiences.

    60% confidence
  • Increasing 5G adoption, growing consumer demand for premium devices, and expansion of digital ecosystems are supporting long-term smartphone market growth.

    60% confidence
  • Asia-Pacific remains a key hub for the smartphones market, supported by strong consumer demand, expanding local manufacturing capabilities, and ongoing investments in mobile technology.

    60% confidence
  • Android segment holds 69.21% market share in the global smartphones market.

    60% confidence
  • Used or refurbished smartphone growth is cannibalizing new device demand, acting as a market restraint.

    60% confidence
  • The Used and Refurbished Smartphone Market is expected to reach USD 69.66 billion in 2026 and grow to USD 96.99 billion by 2031, registering a CAGR of 6.84% during the forecast period.

    60% confidence
  • The smartphones market size is expected to grow from USD 609.29 billion in 2026 and is forecast to reach USD 739.23 billion by 2031, registering a CAGR of 3.94% during 2026-2031.

    60% confidence
  • Geopolitics and tariffs are shifting SKUs and raising logistics complexity as a market restraint.

    60% confidence
  • Memory supply tightness lifts bill-of-materials costs, pressuring low-end Android devices.

    60% confidence
  • Advanced AI capabilities are becoming a key factor influencing smartphone purchases, with consumers attracted to smarter personalization, improved photography, real-time language assistance, and productivity tools on the handset.

    60% confidence
  • The growing availability of budget-friendly 5G smartphones is helping accelerate adoption across developing markets.

    60% confidence
  • The Middle East and Africa Smartphones Market is projected to reach USD 33.95 billion in 2026 and expand to USD 50.14 billion by 2031, growing at a CAGR of 8.12%.

    60% confidence
  • The Foldable Smartphone Market is expected to reach USD 38.68 billion in 2026 and grow to USD 110.19 billion by 2031, registering a CAGR of 23.29% during the forecast period.

    60% confidence
  • As smartphone market dynamics continue to evolve across regions and price segments, decision-makers require analysis grounded in consistently applied research standards and transparent evaluation of market developments.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com